Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

S.E.L.A.R.L. PHARMACIE VANBREMEERSCH : revenue, balance sheet and financial ratios

S.E.L.A.R.L. PHARMACIE VANBREMEERSCH is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in DUNKERQUE (59430), this company of category PME shows in 2025 a net income positive of 60 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - S.E.L.A.R.L. PHARMACIE VANBREMEERSCH (SIREN 828689711)
Indicator 2025 2024 2023 2022 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 59 900 € 114 215 € 95 705 € 235 741 € 201 500 € 198 807 € 211 595 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, S.E.L.A.R.L. PHARMACIE VANBREMEERSCH generates positive net income of 60 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 212 k€ -> 60 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

59 900 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 594%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

594.028%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.813%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

12.1%

Solvency indicators evolution
S.E.L.A.R.L. PHARMACIE VANBREMEERSCH

Sector positioning

Debt ratio
594.03 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch +17 pts over 3 years

In 2025, the debt ratio of S.E.L.A.R.L. PHARMACIE VA... (594.03) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
12.81% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch -22 pts over 3 years

In 2025, the financial autonomy of S.E.L.A.R.L. PHARMACIE VA... (12.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 155.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

155.145

Liquidity indicators evolution
S.E.L.A.R.L. PHARMACIE VANBREMEERSCH

Sector positioning

Liquidity ratio
155.15 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -38 pts over 3 years

In 2025, the liquidity ratio of S.E.L.A.R.L. PHARMACIE VA... (155.15) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH is estimated at 951 518 € (range 645 705€ - 1 493 063€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
645k€ 951k€ 1493k€
951 518 € Range: 645 705€ - 1 493 063€
NAF 5 année 2025

Valuation method used

Net Income Multiple
59 900 € × 15.9x = 951 519 €
Range: 645 705€ - 1 493 064€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare S.E.L.A.R.L. PHARMACIE VANBREMEERSCH with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about S.E.L.A.R.L. PHARMACIE VANBREMEERSCH

What is the revenue of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH ?

The revenue of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH is not publicly disclosed (confidential accounts filed with INPI).

Is S.E.L.A.R.L. PHARMACIE VANBREMEERSCH profitable?

Yes, S.E.L.A.R.L. PHARMACIE VANBREMEERSCH generated a net profit of 60 k€ in 2025.

Where is the headquarters of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH ?

The headquarters of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH is located in DUNKERQUE (59430), in the department Nord.

Where to find the tax return of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH ?

The tax return of S.E.L.A.R.L. PHARMACIE VANBREMEERSCH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does S.E.L.A.R.L. PHARMACIE VANBREMEERSCH operate?

S.E.L.A.R.L. PHARMACIE VANBREMEERSCH operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.